- Home
- BIIB vs ZM Comparison
BIIB vs ZM Comparison
Compare BIIB & ZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIIB
- ZM
- Stock Information
- Founded
- BIIB 1978
- ZM 2011
- Country
- BIIB United States
- ZM United States
- Employees
- BIIB N/A
- ZM N/A
- Industry
- BIIB Biotechnology: Pharmaceutical Preparations
- ZM Computer Software: Programming Data Processing
- Sector
- BIIB Health Care
- ZM Technology
- Exchange
- BIIB Nasdaq
- ZM Nasdaq
- Market Cap
- BIIB 24.2B
- ZM 25.5B
- IPO Year
- BIIB 1991
- ZM 2019
- Fundamental
- Price
- BIIB $168.52
- ZM $84.51
- Analyst Decision
- BIIB Buy
- ZM Buy
- Analyst Count
- BIIB 24
- ZM 26
- Target Price
- BIIB $174.62
- ZM $91.67
- AVG Volume (30 Days)
- BIIB 1.8M
- ZM 2.5M
- Earning Date
- BIIB 10-30-2025
- ZM 11-24-2025
- Dividend Yield
- BIIB N/A
- ZM N/A
- EPS Growth
- BIIB N/A
- ZM 35.88
- EPS
- BIIB 10.97
- ZM 3.80
- Revenue
- BIIB $10,065,900,000.00
- ZM $4,753,621,000.00
- Revenue This Year
- BIIB $2.97
- ZM $6.70
- Revenue Next Year
- BIIB N/A
- ZM $3.35
- P/E Ratio
- BIIB $15.27
- ZM $22.19
- Revenue Growth
- BIIB 4.77
- ZM 3.63
- 52 Week Low
- BIIB $110.04
- ZM $64.41
- 52 Week High
- BIIB $175.86
- ZM $92.80
- Technical
- Relative Strength Index (RSI)
- BIIB 74.64
- ZM 53.19
- Support Level
- BIIB $151.83
- ZM $80.82
- Resistance Level
- BIIB $157.79
- ZM $85.75
- Average True Range (ATR)
- BIIB 5.59
- ZM 2.10
- MACD
- BIIB 1.37
- ZM -0.06
- Stochastic Oscillator
- BIIB 95.37
- ZM 42.71
About BIIB Biogen Inc.
Biogen is an established biopharmaceutical company focused on treatments for neurological diseases and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 45% of total revenue in 2024. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (18% of total in 2024), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).
About ZM Zoom Video Communications Inc.
Zoom Video Communications provides a communications platform that connects people through video, voice, chat, and content sharing. The company's cloud-native platform enables face-to-face video and connects users across various devices and locations in a single meeting. Zoom, which was founded in 2011 and is headquartered in San Jose, California, serves companies of all sizes from all industries around the world.